Figure 2From: Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study Proportions of patients with plasma HIV-1 RNA < 50 copies/mL (Panel A) and < 400 copies/mL (Panel B) for the total intent-to-treat population (X), and for the treatment-naive (♦), restart (■) and switch (▲) sub-groups.Back to article page